Clinical Trial Update: Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating gemcitabine, docetaxel, and capecitabine with stereotactic radiosurgery in pancreatic cancer; the study was terminated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Pancreatic Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2011-05-26